Evaluation of the Pulmonary Vascular Reactivity Test in Patients With Pulmonary Arterial Hypertension and a Cardiac Shunt
NCT02138708 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2026-04-08
Summary
The purpose of this study is to assess the predictive performance of the pulmonary vascular reactivity to acetylcholine, in the presence pulmonary arterial hypertension (estimated 1 year after the closure of the shunt).
Conditions
- Pulmonary Arterial Hypertension With Congenital Cardiac Shunt
Interventions
- OTHER
-
Pharmacological test of pulmonary endothelial
Sponsors & Collaborators
-
URC-CIC Paris Descartes Necker Cochin
collaborator OTHER -
Assistance Publique - Hôpitaux de Paris
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-31
- Primary Completion
- 2016-03-31
- Completion
- 2016-03-31
More Related Trials
-
The Role of Endothelin in Pulmonary Hypertension
NCT00759408 ·Status: COMPLETED ·Phase: PHASE2
-
Open-label, Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study (A2301E1) in Japan
NCT02042014 ·Status: COMPLETED ·Phase: PHASE3
-
Combined Use of Angiography, Optical Coherence Tomography and Intravascular Ultrasound in Evaluation of Pulmonary Vascular Structure and Function in Patients With Pulmonary Arterial Hypertension Treated With Oral Bosentan
NCT01508780 ·Status: WITHDRAWN ·Phase: PHASE4
-
Utility of Exercise-induced N-terminal (NT) Pro-brain Natriuretic Peptide Levels in Predicting Prognosis in Asymptomatic Aortic Stenosis
NCT00567437 ·Status: TERMINATED ·Phase: NA
-
Persistent Pulmonary Hypertension of the Newborn
NCT01389856 ·Status: TERMINATED ·Phase: PHASE3
-
Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial Hypertension
NCT00323024 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants
NCT04955990 ·Status: TERMINATED ·Phase: PHASE4
-
Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants
NCT05764265 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Macitentan in Children Below 2 Years of Age
NCT05731492 ·Status: WITHDRAWN ·Phase: PHASE1
-
Medication Reconciliation in Pulmonary Hypertension
NCT04744584 ·Status: COMPLETED
-
Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension
NCT02782052 ·Status: WITHDRAWN ·Phase: PHASE3
-
Long-term Extension Study of the Safety and Pharmacokinetics of QCC374 in PAH Patients
NCT02939599 ·Status: TERMINATED ·Phase: PHASE2
-
129 Xenon Imaging in Patients Treated With Sotatercept
NCT06351345 ·Status: RECRUITING ·Phase: PHASE2
-
Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease
NCT02742909 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction
NCT02070991 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Longitudinal Study of Patients With Idiopathic Pulmonary Arterial Hypertension, Family or Taking Anorectics
NCT01185730 ·Status: COMPLETED ·Phase: NA
-
Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)
NCT02576002 ·Status: COMPLETED
-
Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension
NCT02080533 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of ACT-293987 (NS-304) in Pulmonary Arterial Hypertension (PAH)
NCT00993408 ·Status: COMPLETED ·Phase: PHASE2
-
the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension
NCT02061787 ·Status: RECRUITING
-
Retrospective Data Analysis of Data From the Zurich PH Registry
NCT03198910 ·Status: COMPLETED
-
The Impact of ERA Switching on Risk Stratification in Pulmonary Arterial Hypertension
NCT07013149 ·Status: RECRUITING
-
National Registry and Cohort Study of Pulmonary Vascular Disease
NCT05368467 ·Status: RECRUITING
-
Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension
NCT05135000 ·Status: TERMINATED ·Phase: PHASE2
-
Bosentan In Exercise Induced Pulmonary Arterial Hypertension in CongenitaL Heart diseasE
NCT01827059 ·Status: UNKNOWN ·Phase: PHASE2